CLINICAL_TRIALS
withdrawal
· 2022-08-05
Clinical Trial Update: Efficacy and Safety of Magnólia Nasal Gel in the Treatment of Allergic Rhinitis [Phase 3]
Summary
Phase 3 trial of Magnólia nasal gel for allergic rhinitis was withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: EMS | Conditions: Allergic Rhinitis | Phase 3 | Status: WITHDRAWN